{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Clindamycin Hydrochloride is an antibiotic used to treat bacterial infections, such as skin, respiratory, and dental infections. It comes as oral capsules in strengths of 75 mg, 150 mg, and 300 mg, available by prescription from Glenmark Pharmaceuticals. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Clindamycin hydrochloride \u2014 ANDA 216957 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216957", "mediaType": "text/html", "title": "Clindamycin hydrochloride"}], "identifier": "ANDA216957", "issued": "2016-09-16", "keyword": ["drug-manufacturers", "medications", "pharmaceuticals", "prescription-drugs", "public-health"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Clindamycin hydrochloride"}